Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Armodafinil Adjunctive Therapy in Bipolar I Depression
NCT01072630Phase 3Completed
- Sponsor
- Cephalon, Inc.
- Start
- Mar 2010
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of armodafinil in bipolar I disorder, sponsored by Cephalon, Inc.. Started Mar 2010; status: completed.
02
Drugs
armodafinil
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT01072630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01072630.